Thus, it would be interesting to identify small-molecule compound(s), such as natural product(s), that can specifically induce endogenous expression of ALOX5 expression in AML cells, and such compound(s) can be applied together with standard chemotherapy to treat MLL-rearranged AML. The gene discussed is KMT2A; the disease is acute myeloid leukemia.